US Medical Devices Reimbursement Market

ID: MRFR/MED/13155-HCR 100 Pages Vikita Thakur Last Updated: September 15, 2026
US Medical Devices Reimbursement Market Research Report: By Medical Device Type (Diagnostic Devices, Surgical Devices, Therapeutic Devices), By Payer Type (Private Insurance, Public Insurance, Out of Pocket), By Reimbursement Model (Fee-for-Service, Capitation, Bundled Payments) and By Provider Type (Hospitals, Clinics, Home Healthcare) - Growth & Industry Forecast 2025 To 2035
US Medical Devices Reimbursement Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)12.39%
2024 Market Size$ 134.7 Billion
2025 Market Size$ 151.39 Billion
2035 Market Size$ 486.87 Billion
Key Players
Medtronic
Boston Scientific
Abbott Laboratories
Johnson & Johnson
Stryker Corporation
B. Braun Melsungen AG
Trends
  • Shift Towards Value-Based Reimbursement
  • Integration of Digital Health Technologies
  • Regulatory Changes Impacting Reimbursement
Opportunities
  • Technological Advancements in Medical Devices
  • Aging Population and Chronic Disease Prevalence
  • Focus on Cost-Effectiveness and Health Economics
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Medical Device, BY Type (USD Billion)
      1. 4.1.1 Diagnostic Devices
      2. 4.1.2 Surgical Devices
      3. 4.1.3 Therapeutic Devices
    2. 4.2 Medical Device, BY Payer Type (USD Billion)
      1. 4.2.1 Private Insurance
      2. 4.2.2 Public Insurance
      3. 4.2.3 Out of Pocket
    3. 4.3 Medical Device, BY Reimbursement Model (USD Billion)
      1. 4.3.1 Fee-for-Service
      2. 4.3.2 Capitation
      3. 4.3.3 Bundled Payments
    4. 4.4 Medical Device, BY Provider Type (USD Billion)
      1. 4.4.1 Hospitals
      2. 4.4.2 Clinics
      3. 4.4.3 Home Healthcare
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Medical Device
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Medtronic (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Boston Scientific (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Abbott Laboratories (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Johnson & Johnson (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Stryker Corporation (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 B. Braun Melsungen AG (DE)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Siemens Healthineers (DE)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Philips Healthcare (NL)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 GE Healthcare (US)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY TYPE
    3. 6.3 US MARKET ANALYSIS BY PAYER TYPE
    4. 6.4 US MARKET ANALYSIS BY REIMBURSEMENT MODEL
    5. 6.5 US MARKET ANALYSIS BY PROVIDER TYPE
    6. 6.6 KEY BUYING CRITERIA OF MEDICAL DEVICE
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF MEDICAL DEVICE
    9. 6.9 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
    11. 6.11 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
    12. 6.12 MEDICAL DEVICE, BY TYPE, 2024 (% SHARE)
    13. 6.13 MEDICAL DEVICE, BY TYPE, 2024 TO 2035 (USD Billion)
    14. 6.14 MEDICAL DEVICE, BY PAYER TYPE, 2024 (% SHARE)
    15. 6.15 MEDICAL DEVICE, BY PAYER TYPE, 2024 TO 2035 (USD Billion)
    16. 6.16 MEDICAL DEVICE, BY REIMBURSEMENT MODEL, 2024 (% SHARE)
    17. 6.17 MEDICAL DEVICE, BY REIMBURSEMENT MODEL, 2024 TO 2035 (USD Billion)
    18. 6.18 MEDICAL DEVICE, BY PROVIDER TYPE, 2024 (% SHARE)
    19. 6.19 MEDICAL DEVICE, BY PROVIDER TYPE, 2024 TO 2035 (USD Billion)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.2.2 BY PAYER TYPE, 2025-2035 (USD Billion)
      3. 7.2.3 BY REIMBURSEMENT MODEL, 2025-2035 (USD Billion)
      4. 7.2.4 BY PROVIDER TYPE, 2025-2035 (USD Billion)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Medical Devices Reimbursement Markets Reimbursement Markets Reimbursement Markets Reimbursement Market Segmentation

US Medical Devices Reimbursement Markets Reimbursement Markets Reimbursement Market By Type (USD Billion, 2025-2035)

  • Diagnostic Devices
  • Surgical Devices
  • Therapeutic Devices

US Medical Devices Reimbursement Markets Reimbursement Markets Reimbursement Market By Payer Type (USD Billion, 2025-2035)

  • Private Insurance
  • Public Insurance
  • Out of Pocket

US Medical Devices Reimbursement Markets Reimbursement Markets Reimbursement Market By Reimbursement Model (USD Billion, 2025-2035)

  • Fee-for-US Medical Devices Reimbursement Market
  • Capitation
  • Bundled Payments

US Medical Devices Reimbursement Markets Reimbursement Markets Reimbursement Market By Provider Type (USD Billion, 2025-2035)

  • Hospitals
  • Clinics
  • Home US Medical Devices Reimbursement Market

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.